Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific C2CD4C FAM148C, KIAA1957, NLF3 ENSG00000183186 C2 calcium-dependent domain containing 4C 19 405438-409170 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055915 Uncertain Approved Vesicles Group enriched 6 adipose tissue: 2.5;cerebral cortex: 10.7;gallbladder: 4.4 endometrium: 0.9 CCL3L3 MGC12815 ENSG00000276085 Chemokine (C-C motif) ligand 3-like 3 17 36194869-36196758 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 bone marrow: 7.4;gallbladder: 1.5 lymph node: 0.5 GLYATL2 BXMAS2-10, MGC24009 ENSG00000156689 Glycine-N-acyltransferase-like 2 11 58834065-58904215 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA060292, HPA065454 Uncertain Approved Mitochondria Group enriched 6 breast: 14.1;cervix, uterine: 27.3;gallbladder: 11.0 salivary gland: 3.0 MUC5B MG1, MUC5 ENSG00000117983 Mucin 5B, oligomeric mucus/gel-forming 11 1223066-1262172 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008246, CAB009396 Supported Validated Vesicles Group enriched 11 cervix, uterine: 347.7;gallbladder: 346.8 colon: 32.6 ABCC2 CMOAT, cMRP, DJS, MRP2 ENSG00000023839 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 10 99782732-99852192 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004860, CAB037271 Approved Group enriched 10 duodenum: 44.7;gallbladder: 42.8;kidney: 20.8;liver: 67.6;small intestine: 50.5 breast: 4.3 AC234582.2 ENSG00000279986 1 155188587-155189452 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Group enriched 5 esophagus: 6.9;fallopian tube: 6.0;gallbladder: 21.0;lung: 6.9;stomach: 30.2 kidney: 2.6 ACE2 ENSG00000130234 Angiotensin I converting enzyme 2 X 15561033-15602148 Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000288, CAB026174 Supported Group enriched 6 duodenum: 186.1;gallbladder: 100.6;kidney: 93.3;small intestine: 266.6;testis: 92.6 heart muscle: 23.1 AKR1C2 BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD ENSG00000151632 Aldo-keto reductase family 1, member C2 10 4922564-5135226 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB047304, HPA068265 Approved Approved Nucleus
Nucleoli fibrillar center
Endoplasmic reticulum
Cytosol Group enriched 5 adipose tissue: 352.3;breast: 122.0;esophagus: 118.4;gallbladder: 189.9;liver: 186.5;stomach: 138.5;urinary bladder: 186.3 duodenum: 33.7 ANXA13 ANX13 ENSG00000104537 Annexin A13 8 123680794-123737407 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018535, HPA019569, HPA019650, CAB025135 Supported Supported Plasma membrane Group enriched 5 duodenum: 304.7;fallopian tube: 91.6;gallbladder: 228.3;small intestine: 240.9 rectum: 39.8 ARC Arg3.1, KIAA0278 ENSG00000198576 Activity-regulated cytoskeleton-associated protein 8 142611044-142614472 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA056430 Approved Vesicles
Microtubules Group enriched 7 adipose tissue: 14.1;adrenal gland: 13.4;cerebral cortex: 14.4;gallbladder: 3.3;seminal vesicle: 5.5 placenta: 1.4 B3GALT5 B3GalT-V, B3T5, beta3Gal-T5, GLCT5 ENSG00000183778 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 21 39556442-39673137 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA054092, HPA054684 Approved Group enriched 5 colon: 23.1;duodenum: 28.2;gallbladder: 8.6;rectum: 41.3;small intestine: 37.9 stomach: 5.1 CCKAR ENSG00000163394 Cholecystokinin A receptor 4 26481400-26490462 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 9 gallbladder: 47.3;stomach: 14.9 tonsil: 3.2 CEACAM6 CD66c, NCA ENSG00000086548 Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) 19 41750977-41772208 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008370, HPA011041 Supported Group enriched 6 bone marrow: 110.9;colon: 184.1;esophagus: 174.2;gallbladder: 190.2;lung: 406.1;rectum: 236.9 appendix: 38.9 CES1 CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1 ENSG00000198848 Carboxylesterase 1 16 55802851-55833337 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012023, HPA046717 Supported Validated Endoplasmic reticulum Group enriched 7 gallbladder: 400.5;liver: 1099.6;lung: 229.6 adipose tissue: 79.7 CHRDL2 BNF1 ENSG00000054938 Chordin-like 2 11 74696429-74731385 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021771 Uncertain Uncertain Mitochondria Group enriched 9 appendix: 162.3;endometrium: 128.0;gallbladder: 169.0;smooth muscle: 181.2;urinary bladder: 45.0 cervix: 14.5 CLRN3 MGC32871, TMEM12, USH3AL1 ENSG00000180745 Clarin 3 10 127877841-127892947 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA014482 Approved Group enriched 8 colon: 71.2;duodenum: 75.4;gallbladder: 23.7;kidney: 43.9;liver: 40.2;rectum: 77.5;small intestine: 99.5 appendix: 7.5 CRP PTX1 ENSG00000132693 C-reactive protein, pentraxin-related 1 159712289-159714589 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005036, HPA027367, HPA027396 Supported Group enriched 68 gallbladder: 173.7;liver: 532.4 endometrium: 5.2 CYP2C18 CPCI, CYP2C, CYP2C17, P450IIC17 ENSG00000108242 Cytochrome P450, family 2, subfamily C, polypeptide 18 10 94683621-94736190 Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 10 duodenum: 105.9;esophagus: 24.7;gallbladder: 24.5;liver: 97.7;small intestine: 90.0;stomach: 62.7 tonsil: 6.4 DEFB4A DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1 ENSG00000171711 Defensin, beta 4A 8 7894629-7896711 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 esophagus: 6.0;gallbladder: 10.4;tonsil: 12.8 cervix: 1.1 DUOX2 LNOX2, P138(TOX), P138-TOX, THOX2 ENSG00000140279 Dual oxidase 2 15 45092650-45114344 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 gallbladder: 448.6;thyroid gland: 124.3;urinary bladder: 90.1 stomach: 38.5 EPS8L3 FLJ21522, MGC16817 ENSG00000198758 EPS8-like 3 1 109750080-109764027 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030998 Approved Approved Vesicles Group enriched 6 colon: 76.3;duodenum: 156.3;gallbladder: 60.0;rectum: 87.4;small intestine: 170.4;stomach: 54.0 appendix: 15.8 ERN2 IRE1b ENSG00000134398 Endoplasmic reticulum to nucleus signaling 2 16 23690309-23713500 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016558 Uncertain Group enriched 6 cervix, uterine: 26.7;colon: 27.8;duodenum: 12.7;gallbladder: 25.2;rectum: 23.4;small intestine: 10.1;stomach: 49.9 appendix: 3.9 F5 ENSG00000198734 Coagulation factor V (proaccelerin, labile factor) 1 169514166-169586588 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002036 Uncertain Approved Golgi apparatus Group enriched 11 gallbladder: 28.5;liver: 93.7;placenta: 67.7 fallopian tube: 5.8 FXYD2 ATP1G1, HOMG2, MGC12372 ENSG00000137731 FXYD domain containing ion transport regulator 2 11 117800844-117828698 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064218, HPA068838 Supported Approved Mitochondria Group enriched 6 gallbladder: 575.2;kidney: 1428.7;salivary gland: 383.4 pancreas: 134.6 GPHA2 A2, GPA2, MGC126572, ZSIG51 ENSG00000149735 Glycoprotein hormone alpha 2 11 64934471-64935888 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 6 gallbladder: 26.4;pancreas: 76.9 testis: 7.9 HABP2 FSAP, HABP, HGFAL, PHBP ENSG00000148702 Hyaluronan binding protein 2 10 113550837-113589602 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019518 Approved Group enriched 12 gallbladder: 56.0;liver: 225.6 stomach: 11.5 HHLA2 B7-H5, B7H7, B7y ENSG00000114455 HERV-H LTR-associating 2 3 108296490-108378285 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA055478 Approved Group enriched 10 colon: 89.3;duodenum: 89.6;gallbladder: 46.3;rectum: 92.1;small intestine: 146.8 stomach: 9.3 HTR1D 5-HT1D, HT1DA, HTRL, RDC4 ENSG00000179546 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled 1 23191895-23194729 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 duodenum: 9.7;gallbladder: 2.5;small intestine: 9.3 fallopian tube: 0.8 LRRC19 FLJ21302 ENSG00000184434 Leucine rich repeat containing 19 9 26993136-27005693 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Group enriched 8 colon: 36.8;duodenum: 24.4;gallbladder: 9.5;kidney: 45.4;rectum: 36.2;small intestine: 35.4 appendix: 3.7 NR1I2 BXR, ONR1, PAR2, PXR, SXR ENSG00000144852 Nuclear receptor subfamily 1, group I, member 2 3 119780484-119818485 FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA029309, HPA055121, HPA073926 Validated Nucleoplasm Group enriched 12 colon: 9.3;duodenum: 23.2;gallbladder: 6.0;liver: 19.7;rectum: 9.4;small intestine: 26.3 stomach: 1.3 ONECUT1 HNF-6, HNF6, HNF6A ENSG00000169856 One cut homeobox 1 15 52756989-52791078 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA003457 Approved Group enriched 6 gallbladder: 8.5;liver: 5.9;pancreas: 2.3;testis: 1.8 bone marrow: 0.7 PDZK1IP1 DD96, MAP17, SPAP ENSG00000162366 PDZK1 interacting protein 1 1 47183593-47191044 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014907 Approved Approved Nuclear speckles
Cytosol Group enriched 6 gallbladder: 299.6;kidney: 1048.6 esophagus: 121.8 PPP1R14D CPI17-like, FLJ20251, GBPI-1, MGC119014, MGC119016 ENSG00000166143 Protein phosphatase 1, regulatory (inhibitor) subunit 14D 15 40815445-40828709 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA041846 Uncertain Group enriched 7 colon: 107.5;duodenum: 114.3;gallbladder: 24.3;rectum: 101.6;small intestine: 91.7 appendix: 12.9 SLC15A1 HPECT1, HPEPT1, PEPT1 ENSG00000088386 Solute carrier family 15 (oligopeptide transporter), member 1 13 98683801-98752654 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA002827 Uncertain Approved Nucleoplasm
Cytosol Group enriched 5 duodenum: 157.7;gallbladder: 68.0;small intestine: 230.1 skin: 27.9 SLC17A4 KIAA2138 ENSG00000146039 Solute carrier family 17, member 4 6 25754699-25781191 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA055564 Approved Group enriched 6 colon: 20.8;duodenum: 29.4;gallbladder: 25.5;liver: 22.4;rectum: 29.4;small intestine: 35.7 pancreas: 4.2 SYT8 DKFZp434K0322 ENSG00000149043 Synaptotagmin VIII 11 1828307-1837521 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA052700 Uncertain Approved Nucleoplasm
Cell Junctions Group enriched 5 gallbladder: 26.7;skin: 80.3;urinary bladder: 25.5 seminal vesicle: 8.5 TM4SF4 il-TMP ENSG00000169903 Transmembrane 4 L six family member 4 3 149473974-149503281 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046430 Supported Approved Plasma membrane
Cytosol Group enriched 34 duodenum: 595.8;gallbladder: 1326.5;liver: 343.7;small intestine: 515.2 stomach: 20.3 UGT1A5 UGT1E ENSG00000240224 UDP glucuronosyltransferase 1 family, polypeptide A5 2 233712992-233773299 Enzymes, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 7 duodenum: 7.7;gallbladder: 3.9;small intestine: 6.9 liver: 0.9 UGT2B15 UGT2B8 ENSG00000196620 UDP glucuronosyltransferase 2 family, polypeptide B15 4 68537413-68670628 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045108 Approved Group enriched 6 colon: 23.8;duodenum: 30.6;gallbladder: 114.5;liver: 108.6;small intestine: 33.9 stomach: 10.2 VNN1 Tiff66 ENSG00000112299 Vanin 1 6 132681590-132714049 Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA064145 Approved Group enriched 5 duodenum: 176.1;gallbladder: 175.5;liver: 142.6;small intestine: 108.8 kidney: 27.4